PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40126C00054Eo 14398 fy26 BAA: national institute — National Institute for Pharmaceutical Technology & Education Inc

National Institute for Pharmaceutical Technology & Education Inc holds $1.5M across 3 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 3 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Aug 31, 2028 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs
Awarding office
National Institute for Pharmaceutical Technology & Education Inc
Recipient
Aug 31, 2028
PoP end
$1.5M
Obligated
$1.5M
Potential
541715
NAICS
AJ12
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75F40126C00054
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentNational Institute for Pharmaceutical Technology & Education Inc
CAGE4XQ36
UEIRKVKGV1CJDB8
NAICS541715
PSCAJ12
Place of performanceMINNEAPOLIS MN
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startSep 1, 2026
PoP end (current)Aug 31, 2028
Obligated$1.5M
Current value$1.5M
Potential value$1.5M

Eo 14398 FY26 BAA: National Institute for Pharmaceutical Technology & Education (BAA FY26C1BP4) is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by National Institute for Pharmaceutical Technology & Education Inc. Estimated value $1.5M ($1.5M obligated). Current period of performance ends Aug 31, 2028. Last award drew 1 bidder. Place of performance: MINNEAPOLIS MN.

Eo 14398 fy26 baa: national institute for pharmaceutical technology & education (baa fy26c1bp4)

Recompete timing

Public
● Expiring in 684 days

Current PoP ends Aug 31, 2028 (684 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 3, 2027.

Want the durability read on 75F40126C00054? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

National Institute for Pharmaceutical Technology & Education Inc — $1.5M obligated across 3 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$1.5M · 100% of firm total
Open full company profile →

Related awards

Same incumbent
75F40122C00192
CONTINUOUS DRUG SUBSTANCE MANUFACTURING FROM BIOMASS-DERIVED BUILDING BLOCKS BAA PMQWP #35…
$3.0M
Sep 28, 2027
75F40122C00122
A MODEL-BASED SYSTEMS ENGINEERING APPROACH TO END-TO-END PHARMACEUTICAL MANUFACTURING OF L…
$4.3M
Sep 29, 2027
75F40126C00069
BAA CONTRACT- FY26C2AP9 ADVANCED CMC INDEX AND INTELLIGENCE PLATFORM FOR DRUG QUALITY CONT…
$635K
Sep 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40126C00054?

75F40126C00054 (Eo 14398 fy26 BAA: national institute) is a Fda Office Of Acq Grant Svcs award with a potential value of $1.5M, currently held by National Institute for Pharmaceutical Technology & Education Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40126C00054?

Fda Office Of Acq Grant Svcs awarded 75F40126C00054 to National Institute for Pharmaceutical Technology & Education Inc (potential $1.5M).

Who is the incumbent on 75F40126C00054?

National Institute for Pharmaceutical Technology & Education Inc is the incumbent with $1.5M across 3 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2028.

When does National Institute for Pharmaceutical Technology & Education Inc’s 75F40126C00054 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 31, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40126C00054? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40126C00054